Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids

Oncogene

Volumn 19, Issue 11, 2000, Pages 1457-1465

  Le, Quan ^a   Dawson, Marcia I ^b   Soprano, Dianne Robert ^a   Soprano, Kenneth J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Palo Alto Institute of Molecular Medicine   (United States)

Author keywords

Conformationally restricted retinoids; RAR agonists; RAR antagonists; Retinoic acid receptors; SCC cells

Indexed keywords

RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL CLONE; CONTROLLED STUDY; EMBRYO; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TRANSACTIVATION;

ANIMALIA;

EID: 0034624704     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203436     Document Type: Article

References (66)

1. Aylsworth CF, Cullum ME, Zile MH and Welsh CW. (1986). J. Natl. Cancer Inst., 76, 339-345.
2. Benner SE, Pajak TF, Lippman SM, Earley C and Hong WK. (1994). J. Natl. Cancer. Inst., 86, 140-141.
3. Bernard BA, Bernardon JM, Delescluse C, Martin B, Lenoir MC, Maignan J, Charpentier B, Pilgrim WR, Reichert U and Shroot B. (1992). Biochem. Biophys. Res. Commun., 186, 977-983.
4. Boring CC, Squires TS and Tong T. (1992). Cancer J. Clin., 42, 19-38.
5. Caliaro MJ, Marmouget C, Guichard S, Mazars P, Valette A, Moisand A, Bugat R and Jozan S. (1994). Int. J. Cancer, 56, 743-748.
6. Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB. (1987). Cancer Res., 47, 936-942.
7. Castaigne S, Chomienne C, Daniel MT, Ballerini P, Berger R, Fenaux P and Degos L. (1990). Blood, 76, 1704-1709.
8. Chao WR, Hobbs PD, Jong L, Zhang XK, Zheng Y, Wu Q, Shroot B and Dawson MI. (1997). Cancer Lett., 115, 1-7.
9. Cline PR and Rice RH. (1983). Cancer Res., 43, 3203-3207.
10. Cosenza SC, Owen TA, Soprano DR and Soprano KJ. (1988). J. Biol. Chem., 263, 12751-12758.
11. Crowe DL. (1998). Cancer Res., 58, 142-148.
12. Darwiche N, Celli G, Tennenbaum T, Glick AB, Yuspa SH and DeLuca LM. (1995). Cancer Res., 55, 2774-2782.
13. Dawson MI, Jong L, Hobbs PD, Cameron JF, Chao WR, Pfahl M, Lee MO, Shroot B and Pfahl M. (1995). J. Med. Chem., 38, 3368-3383.
14. Dawson MI, Chao W, Hobbs PD and Zhang X. (1998). Cancer Lett., 133, 1-8.
15. De Luca LM. (1991). FASEB J., 5, 2924-2933.
16. Grunt TW, Somay C, Oeller H, Dittrich E and Dittrich C. (1992). J. Cell Sci., 103, 501-509.
17. Grunt TW, Somay C, Pavelka M, Ellinger A, Dittrich E and Dittrich C. (1991). J. Cell Sci., 100, 657-666.
18. Gudas L, Sporn MB and Roberts AB. (1994). The Retinoids: Biology, Chemistry and Medicine. 2nd edition. Sporn MB, Roberts AB and Goodman DS (eds). Chapter 11 Raven Press, New York. pp. 443-520.
19. Harnish DC, Jiang H, Soprano KJ, Kochhar DM and Soprano DR. (1992). Der. Dynamics, 194, 239-246.
20. Harant H, Korschineck I, Krupitza G, Fazeny B, Dittrich C and Grunt TW. (1993). Br. J. Cancer, 68, 530-536.
21. Hawley RG, Lieu FH, Fong AZ and Hawley TS. (1994). Gene Therapy. 1, 136-138.
22. Hermann T, Hoffmann B, Zhang XK, Tran P and Pfahl M. (1992). Mol. Endocrinol., 6, 1153-1162.
23. Heyman RA, Mangelsdorr DJ, Dyck JA, Stein RB, Eichele G, Evans RM and Thaller C. (1992). Cell, 68, 397-406.
24. Hong WK and Itri LM. (1994). The Retinoids: Biology, Chemistry and Medicine. 2nd edition. Sporn MB, Roberts AB and Goodman DS (eds). Chapter 15, Raven Press: New York. pp. 597-630.
25. Hu L, Crowe DL, Rheinwald JG, Chambon P and Gudas LJ. (1991). Cancer Res., 51, 3972-3981.
26. Kim KH, Schwartz R and Fuchs E. (1984). Proc. Natl. Acad. Sci. USA, 81, 4280-4284.
27. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen CI, Rosenberger M and Grippo JF. (1992). Nature, 353, 359-361.
28. Liu Y, Lee MO, Wang HG, Li Y, Hashimoto Y, Klaus M, Reed JC and Zhang X. (1996). Mol. Cell Biol., 16, 1138-1149.
29. Lotan R, Xu XC, Lippman SM, Ro JY, Lee JS, Lee JJ and Hong WK. (1995). N. Engl. J. Med., 332, 1405-1410.
30. Lotan R. (1994). Cancer Res., 54, 1987s-1990s.
31. Lotan R, Lotan D and Sacks PG. (1990). Methods Enzymol., 190, 100-110.
32. Lotan R, Pieniazek J, George MD and Jetten AM. (1992). J. Cell. Physiol., 151, 94-102.
33. Lotan R, Sacks PG, Lotan D and Hong WK. (1987). Int. J. Cancer, 40, 224-229.
34. Mangelsdorf DJ, Umesono K and Evans RM. (1994). The Retinoids: Biology, Chemistry and Medicine. 2nd edition. Sporn MB, Roberts AB and Goodman DS (eds). Chapter 12, Raven Press: New York. pp. 319-350.
35. Monzon RI, Fillmore C and Hudson LG. (1997). Mol. Pharm., 51, 377-382.
36. Moon RC, Mehta RG and Rao KVN. (1994). The Retinoids: Biology, Chemistry and Medicine. 2nd edition. Sporn MB, Roberts AB and Goodman DS (eds). Chapter 14, Raven Press: New York. pp. 573-596.
37. Munker M, Munker R, Saxton RE and Koeffler HP. (1987). Cancer Res., 47, 4081-4085.
38. Oridate N, Esumi N, Lotan D, Hing WK, Rochette-Egly C, Chambon P and Lotan R. (1996). Oncogene, 12, 2019-2028.
39. Owen TA, Cosenza SC, Soprano DR and Soprano KJ. (1987). J. Biol. Chem., 262, 15111-15117.
40. Owen TA, Soprano DR and Soprano KJ. (1989). J. Cell Physiol., 139, 424-431.
41. Pear WS, Nolan GP, Scott ML and Baltimore D. (1993). Proc. Natl. Acad. Sci. USA, 90, 8392-8396.
42. Pellegrini R, Mariotti A, Tagliabue E, Bressan R, Bunone G, Coradini D, Delia Vale G, Formelli F, Cleris L, Radice P, Pierotti MA, Colnaghi MI and Menard S. (1995). Cell Growth Differ., 6, 863-869.
43. Rappolee DA, Wang A, Mark D and Werb Z. (1989). J. Cell Biochem., 39, 1-11.
44. Reiss M, Pitman SW und Sartorelli AC. (1985). J. Natl. Cancer Inst., 74, 1015-1023.
45. Rheinwald JG and Beckett MA. (1981). Cancer Res., 41, 1657-1663.
46. Rubin AL and Rice RH. (1986). Cancer Res., 46, 2356-2361.
47. Sakar R and Das SK. (1988). Cancer Let., 41, 225-233.
48. Saunders DE, Christensen C, Wappler NL, Schultz JF, Lawrence WD, Malviya VK, Malone JM and Deppe G. (1993). Anti Cancer Drugs, 4, 201-208.
49. Shao ZM, Dawson MI Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B and Fontana JA. (1995). Oncogene, 11, 493-504.
50. Somay C, Grunt TW, Mannhalter C and Dittrich C. (1992). Br. J. Cancer, 66, 93-98.
51. Somay C, Pavelka M, Ellinger A, Dittrich E and Dittrich C. (1991). J. Cell Sci., 100, 657-666.
52. Soneoka Y, Cannon PM, Ramsdale EE, Griffiths JC, Romano G, Kingsman SM and Kingsman AJ. (1995). Nucleic Acids Res., 23, 628-633.
53. Soprano DR, Chen LX, Wu S, Donigan AM, Borghaei RC and Soprano KJ. (1996). Oncogene, 12, 577-584.
54. Sun SY, Yue P, Dawson MI, Shroot B, Michel S, Lamph WW, Heyman RA, Teng M, Chandraratna RA, Shudo K, Hong WK and Lotan R. (1997). Cancer Res., 57, 4931-4939.
55. Tairis N, Gabriel JL, Soprano KJ and Soprano DR. (1995). J. Biol. Chem., 270, 18380-18387.
56. Thatcher SM, Coe EL and Rice RH. (1985). Differentiation, 29, 82-87.
57. Toscani A, Soprano DR, Cosenza SC, Owen TA and Soprano KJ. (1987). Anal. Biochem., 165, 309-319.
58. Toscani A, Soprano DR and Soprano KJ. (1988). Oncogene Res., 3, 223-238.
59. Volkes EE, Weichselbaum RR, Lippman SM and Hong WK. (1993). N. Engl. J. Med., 328, 184-193.
60. Wilcken NR, Sarcevic B, Musgrove EA and Sutherland RL. (1996). Cell Growth Differ., 7, 65-74.
61. Wong DT, Todd R, Tsuji T and Donoff RB. (1996). Crit. Rev. Oral Biol. Med., 7, 319-328.
62. Wu S, Donigan A, Platsoucas CD, Jung W, Soprano DR and Soprano KJ. (1997a). Exp. Cell Res., 232, 277-286.
63. Wu S, Zhang ZP, Zhang D, Soprano DR and Soprano KJ. (1997b). Exp. Cell. Res., 237, 118-126.
64. Wu S, Zhang D, Donigan A, Dawson MI, Soprano DR and Soprano KJ. (1998a). J. Cell. Biochem., 68, 378-388.
65. Wu S, Zhang D, Zhang ZP, Soprano DR and Soprano KJ. (1998b). Oncogene, 17, 2839-2849.
66. Xu XC, Ro JY, Shin DM, Hong WK and Lotan R. (1994). Cancer Res., 54, 3580-3587.